Navigation Links
Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
Date:5/15/2008

The REACH Registry reveals that 70% of deaths in the stable stroke

population were due to a cardiovascular event other than stroke

NICE, France, May 15 /PRNewswire/ -- New two-year data from the REACH Registry presented at the European Stroke Congress, highlight that among those who die after a stroke the vast majority (73%) will die from nonstroke cardiovascular (CV) events. The overall death rate is 4.45%, with 3.23% of these CV deaths from a nonstroke event.

The two-year data from the REACH Registry demonstrate that the risk of secondary ischemic events (including CV death) is very high in patients with previous stroke and/or TIA.

The REACH Registry has demonstrated that there is a high prevalence of atherothrombosis in more than one vascular bed: one-quarter of patients with coronary artery disease (CAD), two-fifths of patients with cerebrovascular disease (CVD) and three-fifths of patients with peripheral artery disease (PAD) also have atherothrombosis in other arterial locations. REACH Registry data also highlight the undertreatment of patients with CVD in the real-world setting. Improving ischemic risk management in these patients is required to prevent hospitalization and death.

Approximately 28% of patients in the REACH Registry have diagnosed CVD at baseline. About 40% of patients with CVD have polyvascular disease. Of the total CVD population at baseline: 71% suffered a prior stroke; 51% had a prior TIA; and, 20% had both.

Two-year data in the CVD population show high event rates for non-fatal stroke (5.9%). The risk of stroke, MI and CV death at two years was 11.5% for the total CVD population. Patients with a history of CVD are at considerable risk of major adverse cardiac events (MACE) and hospitalizations (>20% at two years).

"CVD patients are at high risk of recurrent stroke and other atherothrombotic events. Moreover the REACH Registry has shown that most of these stable stroke patients are a
'/>"/>

SOURCE REACH Registry
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
2. Biomatricas RNAstable(TM) Stabilizes RNA at Room Temperature
3. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
4. D-Pharm Completes Pre-IND Meeting With the FDA for Treatment of Acute Stroke With DP-b99
5. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
10. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)... platform company has been built upon the foundati...patent that enables contemplative, synthetic brain...y of computational platforms. The emphasis of this...sagging Michigan economy through the creation of t...ed by these artificial minds. , ...
(Date:11/19/2008)...all/ -- Synvista Therapeutics, Inc. (AMEX: SYI ... the FDA has received its application for 510(k) c.... The 510(k) submission begins a 90-day review pr... the kit can be distributed to labs throughout the... "We are very pleased to announce the submission o...
(Date:11/19/2008)...stCall/ -- Jazz Pharmaceuticals,Inc. (Nasdaq: ...te presentation,planned for today at the Lazard C...ue to the proximity of the release of preliminary ...inical trial of JZP-6 (sodium oxybate) for,the tr...cipates that it will release the preliminary top-l...
(Date:11/19/2008)...e first and only FDA-approved once-daily amoxicill...TOWN, Md., Nov. 19 Middl...day announced it has hired the following key comme...nk L. Koos has joined MiddleBrook Pharmaceuticals ...elopment. Koos brings nearly 20 years, experience...
Breaking Biology Technology:Michigan Company Founded upon What Could Be History's Most Important Breakthrough in AI and Robotics 2Michigan Company Founded upon What Could Be History's Most Important Breakthrough in AI and Robotics 3Michigan Company Founded upon What Could Be History's Most Important Breakthrough in AI and Robotics 4Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit 2MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 2MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 3MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 4MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 5
...Wisconsin-Madisons Education Building, which origi...ing has been unfinished for 104 years, but thanks ...odernize and complete the building, one of Bascom ... Tashia F. Morgridge, both UW-Madison alumni, hope...storation effort. That means preserving the buildi...
...on business community, UW campuses , ,MADISON, Wi... Corporate Relations is approaching its first ful...e-year anniversary of receiving its charge from UW...ce and guidance to business community members seek...stem. , ,For a new branch of the university, and o...
...ding from the U.S. Environmental Protection Agenc...earchers will investigate what happens if infectio...c wasting disease and mad cow disease - enter wast...entists Judd Aiken and ,a href="http://www.soils...t="blank">Joel Pedersen currently investigating t...
...ls over the Internet are no longer a pipe dream. T...0 presentation, a panel discussion of Voice over I...ry phone conversations over existing data networks...er Jerry Rocco, an IP telephony specialist with C...one is connected not to a phone jack but to an Eth...
Other Biology Technology:Cisco Chairman donates $31 million for UW building renovation 2UW Office of Corporate Relations nears one-year mile-mark 2UW Office of Corporate Relations nears one-year mile-mark 3UW Office of Corporate Relations nears one-year mile-mark 4Researchers to study fate of prions in wastewater 2VoIP experts assess early implementations 2VoIP experts assess early implementations 3
(Date:11/19/2008)...ndpipe), utilising the patient,s own stem cells, h...an with a failing airway. The bioengineered trache... functioning airway, thereby saving her life. , ...ence that adult stem cells, combined with biologic...ions to other serious illnesses. , In particular...
(Date:11/19/2008)...sity of Central Florida professor show early promi...ate Professor James Turkson,s compounds disrupt th...tests on mice. The compounds, S3I-201 and S3I-M20..., and researchers have observed no negative side e...ng," Turkson said. "They,ve worked very well in mi...
(Date:11/19/2008)...ournal PLoS ONE highlights how the exploration o...the story of a voyage of discovery, starting with ...e molecules responsible and their application as m...uch as sea anemones and corals produce fluorescent...s. Fluorescent proteins have revolutionized biomed...
(Date:11/19/2008)...sity of Central Florida professor show early promi...ate Professor James Turkson,s compounds disrupt th...tests on mice. The compounds, S3I-201 and S3I-M20..., and researchers have observed no negative side e...ng," Turkson said. "They,ve worked very well in mi...
Breaking Biology News(10 mins):Adult stem cell breakthrough 2Adult stem cell breakthrough 32 new compounds show promise for eliminating breast cancer tumors 2Biomedical research profits from the exploration of the deep sea 2Two new compounds show promise for eliminating breast cancer tumors 2Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 588 1Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 588 2Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 588 3Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 588 4Zinc may reduce pneumonia risk in nursing home elderly 910 1Zinc may reduce pneumonia risk in nursing home elderly 910 2Deep Breeze Ltd Launches Unique Non Invasive Radiation Free Pulmonary Imaging System in the U S 4249 1Deep Breeze Ltd Launches Unique Non Invasive Radiation Free Pulmonary Imaging System in the U S 4249 2Deep Breeze Ltd Launches Unique Non Invasive Radiation Free Pulmonary Imaging System in the U S 4249 3Cutting Edge CyberKnife Cancer Treatment Center to Open in Tampa Bay Area 4244 1
...nd unequivocally the coolest - pieces of real esta... containing a state-of-the-art superconducting mag...es such as DNA, RNA, enzymes and other proteins. ...made Bruker magnet was recently completed in a spe...ughly seven and a half tons, the magnetic resonanc...
...ant seeds is endosperm. It has the important task ...ages of its development. In flowering plants, ther...that arises among embryos and endosperm. , They d...ss, and the communication between the two parts of...chers at the Max Planck Institute for Plant Breedi...
...eveloped systems for real-time radiation monitorin...iotherapy (IMRT). IMRT is a radiation therapy for ...curately targeting tumours and minimising the amou...result is that patients only receive a high radiat...preserved. , The problem with IMRT so far, howeve...
...entists who first created "mighty mice" have devel...otechnology firm MetaMorphix, an agent that,s more...a related potential treatment for muscular dystrop...rsion of a cellular docking point for the muscle-l...y injections of the new agent triggered a 60 perce...
Other Biology News:Superconducting magnet attracts molecular research 2The secret love life of plants 2Sensors, a smart dose of medicine for cancer treatment 2Sensors, a smart dose of medicine for cancer treatment 3Mouse study: New muscle-building agent beats all previous ones 2
BacVector-3000 Transfection Kit from Novagen
Highly efficient electroporation solution suitable for transfection of plasmid DNA, oligonucleotides and siRNA. Compatible with all common electroporators.
Removes polysaccharide and phenolic inhibitors of PCR; yields DNA greater than 50 kb in length
Acridine orange, hemizinc salt from Research Organics, Inc.
Biology Products: